Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Phase II clinical trial results demonstrated: Body weight reduction of up to 2% at 48 weeks ( vs 2.1% placebo ) 83% of participants achieved 15% body weight loss at highest dose HbA1c reduction of up to 02% in Type 2 Diabetes participants ( vs 0% placebo ) Normalization of liver fat in 86% of participants with hepatic steatosis Reduction in systolic blood pressure averaging 6-8 mmHg Phase II findings are preliminary
But lyophilization adds a processing step and requires specialized equipment
Structure 27 , 16251633.e1623 (2019)
Moore, K
US$ 28.07
US$ 20.19
US$ 29.66
US$ 29.84
US$ 29.03
US$ 27.84
US$ 20.96
US$ 25.50
US$ 28.04
US$ 27.84
